Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks mixed after disappointing retail sales data

Fri, 24th May 2024 15:19

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

The FTSE 100 index dipped 0.26%, ending the day at 8,317.59 points, while the FTSE 250 saw a gain of 0.68%, closing at 20,770.93.

In currency markets, sterling was last up 0.34% on the dollar to trade at $1.2742, while it edged up 0.01% against the euro, changing hands at €1.1742.

"Following a disappointing session in Asia and Europe, US stock indices shrug off risk-off sentiment amid this week's 'rates higher for longer' outlook as durable goods orders unexpectedly rise," said IG senior market analyst Axel Rudolph.

"The US two-year yield comes slightly off its Thursday 4.95% high while the 10-year yield stalls at the 4.50% marker with the greenback giving back some of this week's gains."

Rudolph noted that over the course of the week, oil prices dropped more than 3% to a near three-month low amid demand concerns, before managing to heave into the green ahead of next week's online OPEC+ meeting.

"US natural gas prices fall by around 2.5% from their five-month peak while the price of gold remains little changed and that of silver rises by around a percentage point ahead of the weekend.

"Next week the focus will remain on inflation with the Fed's preferred PCE inflation gauge."

Retail sales decline more than expected, but consumer confidence improves

In economic news, retail sales in the UK saw a significant decline in April, according to official data released earlier.

The Office for National Statistics reported that retail sales volumes fell by 2.3% last month, following a revised 0.2% decline in March, previously estimated at 0.0%.

Analysts had anticipated a smaller drop of around 0.5%.

The decline was attributed to poor weather, which kept shoppers at home, leading to decreased sales across most sectors, particularly in clothing, sports equipment, games, toys, and furniture.

Non-food store sales volumes fell by 4.1%.

Despite the monthly drop, sales rose by 0.7% in the three months to April compared to the previous quarter.

However, year-on-year sales were down 2.7%, remaining 3.8% below pre-pandemic levels.

The downturn contrasted with recent positive economic indicators, including improved consumer confidence, inflation returning to 2.3%, and the UK exiting a recession with 0.6% growth.

"There was nothing charming about the rainfall that soaked our high streets in April," said Danni Hewson, head of financial analysis at AJ Bell.

"It didn't help that Easter came early. But even then, March's flatlining sales were revised down.

"Consumers are still looking for ways to keep a tight hold on their stretched finances; if they don't need to spend, they probably won't."

In contrast, UK consumer confidence showed signs of improvement in May.

The GfK consumer confidence index rose two points to -17, driven by increased optimism about the economy and personal finances.

Expectations for the general economic situation over the next year climbed four points to -17, while the forward-looking personal finance situation jumped five points to 7.

However, the major purchase index dipped one point to -26.

"With the latest drop in headline inflation and the prospect of interest rate cuts in due course, the trend is certainly positive after a long period of stasis which has seen the overall index score stuck in the doldrums," said Joe Staton, client strategy director at GfK.

"All-in-all, consumers are clearly sensing that conditions are improving.

"This good result anticipates further growth in confidence in the months to come."

On the continent, Germany's economy grew by 0.2% in the first quarter of 2024, according to the Federal Statistics Office, confirming earlier estimates.

It followed a 0.5% contraction in the fourth quarter of the prior year.

The growth rate for the same period in 2023 was 0.3%.

Across the Atlantic, durable goods orders in the US unexpectedly rose by 0.7% in April to $284.1bn, according to the Department of Commerce.

The increase came despite a sharp downward revision to March's figures, which were adjusted from an initial estimate of 2.6% growth to just 0.8%.

However, US consumer sentiment declined in May, according to the University of Michigan's consumer confidence index.

The index fell from 77.2 in April to 69.1 in May, with subindices tracking views on current economic conditions and future expectations both showing decreases.

Retailers rise despite sales data, National Grid falls further

On London's equity markets, retail stocks were in the green despite the ONS reporting a drop in retail sales for April.

Ocado Group surged by 6.16%, Kingfisher rose by 1.31%, and Marks and Spencer Group climbed 2.26%, as investors seemed unfazed by the disappointing sales data.

Packaging group Mondi saw a 0.89% increase after Citi upgraded the stock to 'buy', citing reversing market headwinds in destocking and lower pricing across Mondi's product segments.

Intertek Group also gained 1.26% after confirming its full-year expectations and reporting a 7% growth in like-for-like revenue, driven by a strong recovery in the consumer products segment.

John Wood Group rallied 4.5% after rejecting a third improved takeover proposal from Dubai-based Sidara.

The oil services company stated that the offer of 220p per share still "significantly undervalued" the group and its prospects.

Sidara has until 5 June to make a firm bid.

On the downside, GSK dipped by 0.2%, reversing earlier gains despite a favourable court ruling in Illinois regarding the first Zantac case to go to trial.

National Grid plummeted by 11.5%, continuing its decline after announcing plans for a £7bn equity raise through a rights issue.

United Utilities Group and Severn Trent were also in the red, falling 1.48% and 2.16% respectively.

AJ Bell dropped 3.77% after founder Andy Bell sold 7.5 million shares in the investment platform at 375p each, raising around £28.1m.

Hargreaves Lansdown fell by 3.14% following confirmation that it had rejected a 985p per share takeover offer from a consortium including CVC, Nordic Capital, and Platinum Ivy, a subsidiary of Abu Dhabi Investment Authority.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 8,317.59 -0.26%

FTSE 250 (MCX) 20,770.93 0.68%

techMARK (TASX) 4,853.89 -0.05%

FTSE 100 - Risers

Ocado Group (OCDO) 373.80p 6.16%

Marks & Spencer Group (MKS) 299.20p 2.26%

Intertek Group (ITRK) 5,025.00p 1.43%

Airtel Africa (AAF) 121.00p 1.42%

Phoenix Group Holdings (PHNX) 503.00p 1.41%

Smurfit Kappa Group (CDI) (SKG) 3,882.00p 1.36%

Kingfisher (KGF) 260.90p 1.31%

Legal & General Group (LGEN) 247.90p 1.10%

Aviva (AV.) 488.10p 1.08%

CRH (CDI) (CRH) 6,406.00p 1.04%

FTSE 100 - Fallers

National Grid (NG.) 889.40p -11.50%

RS Group (RS1) 740.50p -2.57%

Fresnillo (FRES) 596.00p -2.21%

Severn Trent (SVT) 2,449.00p -2.16%

Centrica (CNA) 141.15p -1.91%

Smith (DS) (SMDS) 369.60p -1.81%

Haleon (HLN) 323.00p -1.79%

Sage Group (SGE) 1,059.50p -1.76%

Lloyds Banking Group (LLOY) 54.80p -1.76%

SSE (SSE) 1,740.50p -1.64%

FTSE 250 - Risers

Ferrexpo (FXPO) 47.50p 5.79%

NCC Group (NCC) 145.80p 5.19%

Wood Group (John) (WG.) 188.00p 5.17%

SDCL Energy Efficiency Income Trust (SEIT) 64.90p 5.02%

Direct Line Insurance Group (DLG) 210.40p 4.89%

Ibstock (IBST) 171.60p 3.62%

Paragon Banking Group (PAG) 768.50p 3.50%

Plus500 Ltd (DI) (PLUS) 2,234.00p 3.33%

Watches of Switzerland Group (WOSG) 407.80p 3.18%

Travis Perkins (TPK) 858.00p 3.13%

FTSE 250 - Fallers

Essentra (ESNT) 166.40p -4.91%

AJ Bell (AJB) 384.50p -4.59%

Trustpilot Group (TRST) 221.50p -3.08%

PPHE Hotel Group Ltd (PPH) 1,350.00p -2.88%

Hargreaves Lansdown (HL.) 1,090.00p -2.68%

Kainos Group (KNOS) 1,236.00p -2.56%

QinetiQ Group (QQ.) 413.60p -2.54%

TBC Bank Group (TBCG) 2,660.00p -2.21%

Tritax Eurobox (GBP) (EBOX) 55.80p -1.76%

Drax Group (DRX) 499.20p -1.64%

More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.